4
Changes in Ownership
TScan Therapeutics, Inc. Filed Acc 0000950170-24-073694
Options or other derivatives
- Director acquired 47,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Klencke Barbara Director | 2024-06-12 | Grant or award · Stock Option (Right to Buy) | +47,500 | 47,500 | D | ||
Loading xslF345X05/ownership.xml…